The rationale, efficacy and safety evidence for tegaserod in the treatment of irritable bowel syndrome

Author: McLaughlin John   Houghton Lesley A  

Publisher: Informa Healthcare

ISSN: 1474-0338

Source: Expert Opinion on Drug Safety, Vol.5, Iss.2, 2006-03, pp. : 313-327

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract